Literature DB >> 6352701

Tripeptidyl aminopeptidase in the extralysosomal fraction of rat liver.

R M Bålöw, U Ragnarsson, O Zetterqvist.   

Abstract

An enzyme which removes tripeptides from the free, NH2-terminal end of oligopeptides has been detected in the extralysosomal fraction of rat liver. The enzyme was partially purified by Sepharose CL-4B and DEAE-cellulose chromatography. The pH optimum was in the neutral range and the apparent native molecular weight was above 10(6), as judged by the Sepharose chromatography. The enzyme cleaved the phosphopeptide Gly-Val-Leu-Arg-Arg-Ala-Ser(P)-Val-Ala (I), first at the Leu-Arg bond and then at the Ala-Ser(P) bond. The cleavage of the former bond was inhibited by Arg-Arg-Ala-Ser(P)-Val-Ala (II), which indicated that both bonds were cleaved by the same enzyme. Km for II was 0.01 mM at pH 6.5-7.5. Val-Leu-Arg-Arg-Ala-Ser(P)-Val-Ala (III) and Leu - Arg - Arg - Ala - Ser(P)-Val-Ala were poor substrates. III was, however, found to be an efficient inhibitor. The Ala-Ser(P) bond of Arg-Arg-Ala-Ser(P)-Val (IV) was cleaved at the same rate as that of II. The enzyme was active also with the unphosphorylated peptides corresponding to II and IV and tolerated the substitution of lysine for the NH2-terminal arginine of the latter peptide. Substitution of guanidovaleric acid for the NH2-terminal arginine of IV and of guanidovaleric acid or epsilon-amino-hexanoic acid for the NH2-terminal arginine of unphosphorylated IV reduced the rate of hydrolysis to insignificant levels, demonstrating the importance of a free NH2 terminus. The results provide evidence of a unique tripeptidyl aminopeptidase.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6352701

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.486


  19 in total

1.  Tripeptidyl Peptidase II Mediates Levels of Nuclear Phosphorylated ERK1 and ERK2.

Authors:  Anne Wiemhoefer; Anita Stargardt; Wouter A van der Linden; Maria C Renner; Ronald E van Kesteren; Jan Stap; Marcel A Raspe; Birgitta Tomkinson; Helmut W Kessels; Huib Ovaa; Herman S Overkleeft; Bogdan Florea; Eric A Reits
Journal:  Mol Cell Proteomics       Date:  2015-06-03       Impact factor: 5.911

2.  Tripeptidyl peptidase II promotes maturation of caspase-1 in Shigella flexneri-induced macrophage apoptosis.

Authors:  H Hilbi; R J Puro; A Zychlinsky
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  The gene encoding tripeptidyl peptidase II maps to chromosome 1 in the mouse.

Authors:  N A Bermingham; T McKay; J Hoyle; D Hernandez; J E Martin; E M Fisher
Journal:  Mamm Genome       Date:  1996-05       Impact factor: 2.957

Review 4.  High molecular mass intracellular proteases.

Authors:  A J Rivett
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

5.  Active site of tripeptidyl peptidase II from human erythrocytes is of the subtilisin type.

Authors:  B Tomkinson; C Wernstedt; U Hellman; O Zetterqvist
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

6.  Distribution of tripeptidyl-peptidase II in the central nervous system of rat.

Authors:  B Tomkinson; F Nyberg
Journal:  Neurochem Res       Date:  1995-12       Impact factor: 3.996

7.  Tripeptidyl peptidase II in haemolysates and liver homogenates of various species.

Authors:  R M Bålöw; I Eriksson
Journal:  Biochem J       Date:  1987-01-01       Impact factor: 3.857

8.  Purification and characterization of tripeptidylpeptidase-II from post-mortem human brain.

Authors:  C Wilson; A M Gibson; J R McDermott
Journal:  Neurochem Res       Date:  1993-07       Impact factor: 3.996

9.  Characterization of cDNA for murine tripeptidyl-peptidase II reveals alternative splicing.

Authors:  B Tomkinson
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

10.  Tripeptidyl peptidase II in human oral squamous cell carcinoma.

Authors:  Katsuya Usukura; Atsushi Kasamatsu; Atsushi Okamoto; Yukinao Kouzu; Morihiro Higo; Hirofumi Koike; Yosuke Sakamoto; Katsunori Ogawara; Masashi Shiiba; Hideki Tanzawa; Katsuhiro Uzawa
Journal:  J Cancer Res Clin Oncol       Date:  2012-09-18       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.